FIBRALIGN CORPORATION
Fibralign Corporation utilizes Nanoweave® a proprietary scaffolding technology to develop advanced biomedical devices. Fibralign has launched its first product, the BioBridge® Collagen Matrix, and is now engaging in clinical studies to evaluate its use for treating and preventing secondary lymphedema, as well as advancing R&D development for new applications for treating ischemia and novel delivery devices for use with stem cells and gene therapy.
FIBRALIGN CORPORATION
Industry:
Biotechnology Clinical Trials Medical Medical Device Therapeutics
Founded:
2007-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.fibralignbio.com
Total Employee:
1+
Status:
Active
Contact:
8313358348
Email Addresses:
[email protected]
Total Funding:
179.96 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Sitelinks Search Box
Current Advisors List
Current Employees Featured
Founder
Investors List
AngelMD
AngelMD investment in Venture Round - Fibralign Corporation
MedTech Innovator
MedTech Innovator investment in Grant - Fibralign Corporation
National Science Foundation
National Science Foundation investment in Grant - Fibralign Corporation
Official Site Inspections
http://www.fibralignbio.com Semrush global rank: 5.97 M Semrush visits lastest month: 1.38 K
- Host name: 44.173.155.104.bc.googleusercontent.com
- IP address: 104.155.173.44
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
